Neurological complications in chronic kidney disease

被引:137
作者
Arnold, Ria [1 ]
Issar, Tushar [2 ]
Krishnan, Arun V. [2 ]
Pussell, Bruce A. [2 ]
机构
[1] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia
[2] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia
来源
JRSM CARDIOVASCULAR DISEASE | 2016年 / 5卷
基金
英国医学研究理事会;
关键词
Chronic kidney disease; neurological complications; uraemic neuropathy; uraemic encephalopathy; cognitive dysfunction; peripheral neuropathy; autonomic neuropathy;
D O I
10.1177/2048004016677687
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with chronic kidney disease (CKD) are frequently afflicted with neurological complications. These complications can potentially affect both the central and peripheral nervous systems. Common neurological complications in CKD include stroke, cognitive dysfunction, encephalopathy, peripheral and autonomic neuropathies. These conditions have significant impact not only on patient morbidity but also on mortality risk through a variety of mechanisms. Understanding the pathophysiological mechanisms of these conditions can provide insights into effective management strategies for neurological complications. This review describes clinical management of neurological complications in CKD with reference to the contributing physiological and pathological derangements. Stroke, cognitive dysfunction and dementia share several pathological mechanisms that may contribute to vascular impairment and neurodegeneration. Cognitive dysfunction and dementia may be differentiated from encephalopathy which has similar contributing factors but presents in an acute and rapidly progressive manner and may be accompanied by tremor and asterixis. Recent evidence suggests that dietary potassium restriction may be a useful preventative measure for peripheral neuropathy. Management of painful neuropathic symptoms can be achieved by pharmacological means with careful dosing and side effect considerations for reduced renal function. Patients with autonomic neuropathy may respond to sildenafil for impotence. Neurological complications often become clinically apparent at end-stage disease, however early detection and management of these conditions in mild CKD may reduce their impact at later stages.
引用
收藏
页数:13
相关论文
共 44 条
  • [1] Adachi Hiroshi, 2007, Journal of Smooth Muscle Research, V43, P179, DOI 10.1540/jsmr.43.179
  • [2] Modulation of stroke risk in chronic kidney disease
    Arnold, Julia
    Sims, Don
    Ferro, Charles J.
    [J]. CLINICAL KIDNEY JOURNAL, 2016, 9 (01) : 29 - 38
  • [3] Association Between Calcineurin Inhibitor Treatment and Peripheral Nerve Dysfunction in Renal Transplant Recipients
    Arnold, R.
    Pussell, B. A.
    Pianta, T. J.
    Lin, C. S. -Y.
    Kiernan, M. C.
    Krishnan, A. V.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (09) : 2426 - 2432
  • [4] Arnold R., 2014, MANAGEMENT CHRONIC K, P343
  • [5] Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease
    Arnold, Ria
    Pussell, Bruce A.
    Howells, James
    Grinius, Virginija
    Kiernan, Matthew C.
    Lin, Cindy S. -Y.
    Krishnan, Arun V.
    [J]. CLINICAL NEUROPHYSIOLOGY, 2014, 125 (01) : 179 - 185
  • [6] Axonal dysfunction prior to neuropathy onset in type 1 diabetes
    Arnold, Ria
    Kwai, Natalie
    Lin, Cindy S-Y.
    Poynten, Ann M.
    Kiernan, Matthew C.
    Krishnan, Arun V.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2013, 29 (01) : 53 - 59
  • [7] Heart Rate Variability Predicts ESRD and CKD-Related Hospitalization
    Brotman, Daniel J.
    Bash, Lori D.
    Qayyum, Rehan
    Crews, Deidra
    Whitsel, Eric A.
    Astor, Brad C.
    Coresh, Josef
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (09): : 1560 - 1570
  • [8] Neurological complications in renal failure: a review
    Brouns, R
    De Deyn, PP
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 107 (01) : 1 - 16
  • [9] Cognitive Disorders and Dementia in CKD: The Neglected Kidney-Brain Axis
    Bugnicourt, Jean-Marc
    Godefroy, Olivier
    Chillon, Jean-Marc
    Choukroun, Gabriel
    Massy, Ziad A.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (03): : 353 - 363
  • [10] Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients
    Chan, Kevin E.
    Ikizler, T. Alp
    Gamboa, Jorge L.
    Yu, Chang
    Hakim, Raymond M.
    Brown, Nancy J.
    [J]. KIDNEY INTERNATIONAL, 2011, 80 (09) : 978 - 985